Priscilla L. Yang

Molecular Biology · 2009

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Molecular Biology — 22 citations into it; #14,710 of 17,773 by trust here, #11,608 by citations
• Hematology — 12 citations into it
• Oncology — 9 citations into it

Whom Priscilla L. Yang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Yi Liu

Who trusts Priscilla L. Yang overall

1. R. Roskoski

Papers from Priscilla L. Yang's perspective

Ordered by how strongly the researchers Priscilla L. Yang trusts endorse each paper. Same corpus, a different order for every researcher.

1. The PIK3CA gene is mutated with high frequency in human breast cancers (Cancer Biology & Therapy)
2. A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
3. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. (New England Journal of Medicine)
4. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth (Nature)
5. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent… (Journal of Medicinal Chemistry)
6. Rational design of inhibitors that bind to inactive kinase conformations (Nature Chemical Biology)
7. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. (Science)
8. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
9. The Protein Kinase Complement of the Human Genome (Science)
10. High Frequency of Mutations of the PIK3CA Gene in Human Cancers (Science)

Their papers

• Targeting cancer with small molecule kinase inhibitors (2009) — 2,565 citations